ENANTA PHARMACEUTICALS INC - Common Stock, par value $0.01 per share (ENTA)

CUSIP: 29251M106

Q4 2014 13F Holders as of 31 Dec 2014

Type / Class
Equity / Common Stock, par value $0.01 per share
Shares outstanding
28,862,345
Total 13F shares
10,443,495
Share change
+246,790
Total reported value
$530,912,559
Put/Call ratio
263%
Price per share
$50.85
Number of holders
122
Value change
+$20,770,064
Number of buys
59
Number of sells
62

Quarterly Holders Quick Answers

What is CUSIP 29251M106?
CUSIP 29251M106 identifies ENTA - ENANTA PHARMACEUTICALS INC - Common Stock, par value $0.01 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of ENANTA PHARMACEUTICALS INC - Common Stock, par value $0.01 per share (ENTA) as of Q4 2014

As of 31 Dec 2014, ENANTA PHARMACEUTICALS INC - Common Stock, par value $0.01 per share (ENTA) was held by 122 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 10,443,495 shares. The largest 10 holders included FMR LLC, Consonance Capital Management LP, EAGLE ASSET MANAGEMENT INC, Apex Capital Management, State Street Corp, BlackRock Fund Advisors, VANGUARD GROUP INC, Marshall Wace LLP, BlackRock Institutional Trust Company, N.A., and WALL STREET ASSOCIATES. This page lists 122 institutional shareholders reporting positions in this security for the Q4 2014 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.